Paroxetine Tablet, Film Coated
Product Images NDC 71610-992

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Paroxetine (NDC 71610-992). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (71610 0992 30)

Paroxetine 40 mg film-coated tablets carton label showing the proprietary name PAROXETINE and active ingredient paroxetine hydrochloride. The label indicates a 30 tablet package with the National Drug Code (NDC) 71610-992-30. It includes storage instructions, manufacturer Aphena Pharma Solutions - Tennessee, LLC, MFG BY Apotex Inc., and RPKG BY Aphena Pharma, Cookeville, TN.*

FDA Label Image

Aphena (Aphena)

FDA Label Image

Figure1.jpg (Figure1)

A scatter plot chart showing fold change and 90% confidence intervals for pharmacokinetic parameters Cmax and AUC of paroxetine hydrochloride when administered with various interacting drugs (Pimozide, Desipramine, Propranolol, Digoxin, Phenytoin). The x-axis represents change relative to reference on a logarithmic scale from 0.1 to 10.0, with data points and error bars for each interacting drug's Cmax and AUC values.*

FDA Label Image

Figure2.jpg (Figure2)

A scatter plot with error bars showing fold changes and 90% confidence intervals in pharmacokinetic parameters Cmax and AUC for various interacting drugs compared to a reference. The x-axis represents the change relative to the reference, ranging from 0 to 2, with multiple drugs plotted including Cimetidine, Phenobarbital, Phenytoin, Digoxin, and Diazepam.*

FDA Label Image

Figure3.jpg (Figure3)

A pharmacokinetic chart showing fold change and 90% confidence intervals of Cmax, Cmin, and AUC parameters relative to reference in populations with renal impairment (mild, moderate, severe), hepatic impairment, age over 65 years at various doses, and gender (males). The x-axis represents change relative to reference on a logarithmic scale from 0.5 to 50.0.*

FDA Label Image

Structure (Structure)

Chemical structure of paroxetine hydrochloride showing its molecular arrangement including a fluorophenyl group and a methylenedioxyphenyl moiety.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.